Xianlin Xu

1.4k total citations · 1 hit paper
39 papers, 978 citations indexed

About

Xianlin Xu is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Xianlin Xu has authored 39 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Xianlin Xu's work include Renal cell carcinoma treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). Xianlin Xu is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Cancer-related molecular mechanisms research (6 papers) and RNA modifications and cancer (6 papers). Xianlin Xu collaborates with scholars based in China, Sweden and United States. Xianlin Xu's co-authors include Min Fan, Xiaozhou He, Xiaozhou He, Renfang Xu, Dongming Chen, Qianfeng Zhuang, Xiaozhou He, Cui Li, Qianqian Shi and Yingjie Shao and has published in prestigious journals such as The Journal of Urology, Journal of Cellular Physiology and BMC Public Health.

In The Last Decade

Xianlin Xu

39 papers receiving 966 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis

2022 92 citations Jing Ge, Wenlong Han et al. BMC Urology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xianlin Xu China	21	388	310	225	217	147	39	978
Wenjie Wang China	20	467 1.2×	224 0.7×	366 1.6×	185 0.9×	246 1.7×	94	1.3k
Maria Ida Amabile Italy	19	354 0.9×	167 0.5×	90 0.4×	264 1.2×	203 1.4×	74	1.2k
Yinhuai Wang China	18	585 1.5×	430 1.4×	262 1.2×	138 0.6×	166 1.1×	86	1.1k
Jun Morinaga Japan	19	374 1.0×	254 0.8×	112 0.5×	129 0.6×	124 0.8×	63	995
David Hoffman United States	23	425 1.1×	116 0.4×	120 0.5×	179 0.8×	148 1.0×	62	2.0k
Chen Huang China	14	288 0.7×	211 0.7×	126 0.6×	156 0.7×	96 0.7×	27	684
Cindy Kok Australia	16	458 1.2×	230 0.7×	328 1.5×	140 0.6×	169 1.1×	43	1.3k
Pablo Cannata Spain	11	373 1.0×	138 0.4×	223 1.0×	59 0.3×	97 0.7×	14	879
Mark Michael Germany	12	333 0.9×	217 0.7×	109 0.5×	217 1.0×	210 1.4×	34	923

Countries citing papers authored by Xianlin Xu

Since Specialization

Citations

This map shows the geographic impact of Xianlin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xianlin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xianlin Xu more than expected).

Fields of papers citing papers by Xianlin Xu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xianlin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xianlin Xu. The network helps show where Xianlin Xu may publish in the future.

Co-authorship network of co-authors of Xianlin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Xianlin Xu. A scholar is included among the top collaborators of Xianlin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xianlin Xu. Xianlin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ge, Jing, Wenlong Han, Dong Wang, et al.. (2022). Risk factors for kidney stone disease recurrence: a comprehensive meta-analysis. BMC Urology. 22(1). 62–62. 92 indexed citations breakdown →

Liu, He, Qi Cheng, Furong Zhang, et al.. (2021). Urinary levels of dimethoate, bisphenol A and benzo[a]pyrene in first-year students of Hohai University from different geographical regions. BMC Public Health. 21(1). 1692–1692. 7 indexed citations

Xu, Xianlin, et al.. (2020). Risk Factors for Postpartum Stress Urinary Incontinence: a Systematic Review and Meta-analysis. Reproductive Sciences. 27(12). 2129–2145. 41 indexed citations

Wu, Zhipeng, Jinhui Liu, Rui Sun, et al.. (2020). A Novel Prognostic Index Based on Alternative Splicing in Papillary Renal Cell Carcinoma. Frontiers in Genetics. 10. 1333–1333. 3 indexed citations

Wang, Kai, Zhen Chen, Yuehua Feng, et al.. (2020). Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells. The Prostate. 80(12). 977–985. 28 indexed citations

Chen, Dongming, Wei Chen, Yong Xu, et al.. (2018). Upregulated immune checkpoint HHLA2 in clear cell renal cell carcinoma: a novel prognostic biomarker and potential therapeutic target. Journal of Medical Genetics. 56(1). 43–49. 56 indexed citations

Yang, Min, Bin Wang, Liying Miao, Xianlin Xu, & Xiaozhou He. (2016). Autophagy is involved in aldosterone-induced mesangial cell proliferation. Molecular Medicine Reports. 14(5). 4638–4642. 5 indexed citations

Luo, Fengbao, et al.. (2016). Mitogen-Activated Protein Kinases and Hypoxic/Ischemic Nephropathy. Cellular Physiology and Biochemistry. 39(3). 1051–1067. 43 indexed citations

Wang, Bin, Xianlin Xu, Xiaozhou He, Zhigang Wang, & Min Yang. (2016). Berberine Improved Aldo-Induced Podocyte Injury via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress Pathways both In Vivo and In Vitro. Cellular Physiology and Biochemistry. 39(1). 217–228. 26 indexed citations

10.

Xu, Renfang, et al.. (2016). Downregulation of lncRNA CASC2 by microRNA-21 increases the proliferation and migration of renal cell carcinoma cells. Molecular Medicine Reports. 14(1). 1019–1025. 74 indexed citations

11.

Chen, Zhen, Yingjie Shao, Kun Wang, et al.. (2016). Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis. OncoTargets and Therapy. Volume 9. 6701–6710. 41 indexed citations

12.

Chen, Zhen, Yingjie Shao, Min Fan, et al.. (2015). Prognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.. PubMed. 8(11). 14893–900. 47 indexed citations

13.

Fan, Min, Xiaozhou He, & Xianlin Xu. (2015). Restored expression levels of TET1 decrease the proliferation and migration of renal carcinoma cells. Molecular Medicine Reports. 12(4). 4837–4842. 21 indexed citations

14.

Shi, Qianqian, et al.. (2015). MicroRNA-877 acts as a tumor suppressor by directly targeting eEF2K in renal cell carcinoma. Oncology Letters. 11(2). 1474–1480. 26 indexed citations

15.

Zhuang, Qianfeng, et al.. (2014). Capn4 mRNA level is correlated with tumour progression and clinical outcome in clear cell renal cell carcinoma. Journal of International Medical Research. 42(2). 282–291. 18 indexed citations

16.

Ding, Tao, Xiaozhou He, Xianlin Xu, et al.. (2014). [Expression of serum FSTL-1 in bone metastasis of prostate cancer and its clinical implication].. PubMed. 20(12). 1090–2. 3 indexed citations

17.

Xu, Xianlin, et al.. (2013). Aging aggravates long-term renal ischemia-reperfusion injury in a rat model. Journal of Surgical Research. 187(1). 289–296. 21 indexed citations

18.

Li, Cui, Hua Zhou, Hu Zhao, et al.. (2012). MicroRNA-99a induces G1-phase cell cycle arrest and suppresses tumorigenicity in renal cell carcinoma. BMC Cancer. 12(1). 546–546. 84 indexed citations

19.

Fan, Min, Xianlin Xu, Xiaozhou He, et al.. (2012). Protective Effects of Hydrogen-Rich Saline Against Erectile Dysfunction in a Streptozotocin Induced Diabetic Rat Model. The Journal of Urology. 190(1). 350–356. 35 indexed citations

20.

Ye, Qing, Guanghua Luo, Xiaozhou He, et al.. (2004). A novel pattern of pp65-positive cytomegalic endothelial cells circulating in peripheral blood from a renal transplant recipient. Acta Histochemica. 106(2). 107–110. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact